XML 26 R20.htm IDEA: XBRL DOCUMENT
v3.26.1

Net Loss Per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Earnings Per Share [Abstract] |
Instruments Excluded from the Computation of Diluted Net Loss Per Share | The following instruments were excluded from the computation of diluted net loss per share for the periods presented because their effect would have been antidilutive (in thousands):
|  | March 31, 2026 |  |  | March 31, 2025 |
Options to purchase common stock |  |  | 11,783 |  |  |  | 11,714 |
Restricted stock and performance units |  |  | 3,085 |  |  |  | 2,498 |
Shares issuable related to the ESPP |  |  | 55 |  |  |  | 66 |
Shares issuable upon conversion of 2026 Notes |  |  | 2,003 |  |  |  | 2,003 |
Shares issuable upon conversion of 2027 Notes |  |  | 2,751 |  |  |  | 10,572 |
Shares issuable upon conversion of 2031 Notes |  |  | 10,962 |  |  |  | — |
Total shares |  |  | 30,639 |  |  |  | 26,853 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration